Companies looking for a treatment for Alzheimer’s have spent a staggering amount of money in recent decades with little to show for it. Some of the upcoming test results are being seen as long shots in the medical and investment communities, meaning the good news will have a seismic impact.
Since 1995, more than 42.5 billion dollars enrolled thousands of patients across more than 1,000 trials. However, to this day there is not a single treatment that can cure or slow down the progression of the disease.
